Legacy Private Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-7,636
Closed -$212K 238
2017
Q2
$212K Sell
7,636
-4,260
-36% -$113K 0.03% 222
2017
Q1
$296K Hold
11,896
0.04% 211
2016
Q4
$257K Sell
11,896
-5,834
-33% -$127K 0.03% 217
2016
Q3
$422K Sell
17,730
-3,650
-17% -$87.1K 0.06% 186
2016
Q2
$500K Sell
21,380
-220
-1% -$4.76K 0.07% 166
2016
Q1
$406K Sell
21,600
-37,680
-64% -$662K 0.06% 181
2015
Q4
$1.09M Buy
59,280
+36,160
+156% +$648K 0.17% 126
2015
Q3
$379K Sell
23,120
-7,720
-25% -$132K 0.06% 193
2015
Q2
$546K Sell
30,840
-4,360
-12% -$77.9K 0.08% 182
2015
Q1
$625K Sell
35,200
-4,260
-11% -$67.3K 0.09% 174
2014
Q4
$523K Buy
39,460
+17,700
+81% +$226K 0.08% 188
2014
Q3
$257K Buy
21,760
+9,600
+79% +$121K 0.04% 222
2014
Q2
$155K Buy
+12,160
New +$158K 0.02% 253

Other funds holding BSX

Legacy Private Trust's BSX Position: Q3 2017 in Review

Legacy Private Trust sold out of Boston Scientific (BSX) in Q3 2017, closing a stake of 7,636 shares — an estimated $212K sold.

Legacy Private Trust first reported a position in BSX in Q2 2014 and held it in 13 quarters. The position peaked at $1.09M in Q4 2015. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

  • Legacy Private Trust reported no remaining Boston Scientific position as of Q3 2017 after selling out during the quarter.
  • Legacy Private Trust sold 7,636 Boston Scientific shares in Q3 2017, an estimated $212K.
  • Legacy Private Trust first reported a position in Boston Scientific in Q2 2014 and held it in 13 quarters.
  • Legacy Private Trust's Boston Scientific position peaked at $1.09M in Q4 2015.
  • 547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Legacy Private Trust's 13F filing for Q3 2017, filed 13 Oct 2017.